End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.69 CNY | 0.00% | +3.50% | +6.95% |
Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
Apr. 19 | Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.95% | 3.19B | |
+25.61% | 660B | |
+23.58% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.68% | 219B | |
-9.90% | 196B | |
+6.79% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Zhejiang Huahai Pharma Unit Cleared to Carry Out Clinical Trial of Solid Tumor Injection